RME.F - ResMed Inc.

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Currency in EUR

Valuation Measures

Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (5Y Monthly) 0.42
52-Week Change 369.34%
S&P500 52-Week Change 324.80%
52 Week High 3146.00
52 Week Low 379.50
50-Day Moving Average 3139.12
200-Day Moving Average 3125.82

Share Statistics

Avg Vol (3 month) 39
Avg Vol (10 day) 31
Shares Outstanding 5143.79M
Float 142.38M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 41.4
Forward Annual Dividend Yield 40.96%
Trailing Annual Dividend Rate 31.52
Trailing Annual Dividend Yield 31.03%
5 Year Average Dividend Yield 41.27
Payout Ratio 451.72%
Dividend Date 3N/A
Ex-Dividend Date 4Nov 06, 2019
Last Split Factor 22:1
Last Split Date 3Aug 31, 2010

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Jun 30, 2019
Most Recent Quarter (mrq)Sep 30, 2019


Profit Margin 15.52%
Operating Margin (ttm)24.56%

Management Effectiveness

Return on Assets (ttm)11.47%
Return on Equity (ttm)20.86%

Income Statement

Revenue (ttm)2.7B
Revenue Per Share (ttm)18.83
Quarterly Revenue Growth (yoy)15.80%
Gross Profit (ttm)1.54B
EBITDA 821.28M
Net Income Avi to Common (ttm)419M
Diluted EPS (ttm)2.90
Quarterly Earnings Growth (yoy)13.60%

Balance Sheet

Total Cash (mrq)172.15M
Total Cash Per Share (mrq)1.2
Total Debt (mrq)1.31B
Total Debt/Equity (mrq)61.66
Current Ratio (mrq)2.11
Book Value Per Share (mrq)14.73

Cash Flow Statement

Operating Cash Flow (ttm)573.29M
Levered Free Cash Flow (ttm)496.76M